Posttraumatic stress disorder and platelet serotonin measures.

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Serotonin (5HT) dysfunction is implicated in PTSD pathophysiology.
• Serotonin-related drugs show therapeutic efficacy in PTSD symptom management.
• Blood platelets serve as a peripheral model for central serotonergic neurons.

Purpose of the Study:

• To investigate alterations in serotonin mechanisms within blood platelets of PTSD patients.
• To assess platelet serotonin levels, serotonin transporter kinetics, and monoamine oxidase B (MAO-B) activity in PTSD.
• To explore the role of peripheral serotonergic markers in the pathophysiology of combat-related PTSD.

Main Methods:

• Assessed platelet serotonin levels, serotonin transporter kinetics (Vmax, Km), and MAO-B kinetics in 63 combat-related PTSD patients and 43 controls.
• Utilized blood platelets as a peripheral model for central serotonergic neurons.
• Compared kinetic parameters and serotonin levels between PTSD patients and matched control subjects.

Main Results:

• A significant reduction (approx. 30%) in the maximal velocity (Vmax) of platelet monoamine oxidase B (MAO-B) was observed in PTSD patients.
• No significant changes were found in MAO-B enzyme affinity in the PTSD group.
• Platelet serotonin transporter kinetics (Vmax, Km) and platelet serotonin levels remained unaltered in PTSD patients compared to controls.

Conclusions:

• The findings suggest a specific alteration in the serotonergic system, particularly in MAO-B activity, associated with PTSD.
• Platelet MAO-B reduction may represent a potential biomarker for PTSD.
• Further research is warranted to elucidate the precise role of MAO-B in PTSD pathophysiology and its therapeutic implications.